Bruker (BRKR) Tops Q3 EPS by 12c, cuts forecast

Bruker (NASDAQ: BRKR) reported Q3 EPS of $0.45, $0.12 better than the analyst estimate of $0.33. Revenue for the quarter came in at $860.5 million versus the consensus estimate of $847 million.

GUIDANCE:

Bruker sees FY2025 EPS of $1.85-$1.90, versus the consensus of $1.94. Bruker sees FY2025 revenue of $3.41-3.44 billion, versus the consensus of $3.44 billion.

For earnings history and earnings-related data on Bruker (BRKR) click here.

You May Also Be Interested In

• Regency Centers (REG) Tops Q2 EPS by 2c
• Kotak Upgrades Mahanagar Gas Limited (MAHGL:IN) to Reduce (3)
• enVVeno Medical (NVNO) Misses Q2 EPS by 537c